Valentina Panzeri
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Ferritin-based nanocarrier delivery of KRAS G12D inhibitor in pancreatic adenocarcinoma cells and patient-derived organoids: A novel approach for treatment.
Journal: Protein science : a publication of the Protein Society
Published: July 23, 2025
DDX21 Controls Cell Cycle Progression and Autophagy in Pancreatic Cancer Cells.
Journal: Cancers
Published: December 23, 2024
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer.
Journal: Cell reports. Medicine
Published: August 03, 2023
CDK12/13 promote splicing of proximal introns by enhancing the interaction between RNA polymerase II and the splicing factor SF3B1.
Journal: Nucleic acids research
Published: October 24, 2022
SEMA6C: a novel adhesion-independent FAK and YAP activator, required for cancer cell viability and growth.
Journal: Cellular and molecular life sciences : CMLS
Published: October 24, 2022
Functional Interaction Between the Oncogenic Kinase NEK2 and Sam68 Promotes a Splicing Program Involved in Migration and Invasion in Triple-Negative Breast Cancer.
Journal: Frontiers in oncology
Published: February 21, 2022
The oncogenic kinase NEK2 regulates an RBFOX2-dependent pro-mesenchymal splicing program in triple-negative breast cancer cells.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 17, 2021
RNA Extraction from Endoscopic Ultrasound-Acquired Tissue of Pancreatic Cancer Is Feasible and Allows Investigation of Molecular Features.
Journal: Cells
Published: October 30, 2020
Gcn5p and Ubp8p Affect Protein Ubiquitylation and Cell Proliferation by Altering the Fermentative/Respiratory Flux Balance in Saccharomyces cerevisiae.
Journal: mBio
Published: August 14, 2020
The RNA-binding protein MEX3A is a prognostic factor and regulator of resistance to gemcitabine in pancreatic ductal adenocarcinoma.
Journal: Molecular oncology
Published: June 09, 2020
c-MYC empowers transcription and productive splicing of the oncogenic splicing factor Sam68 in cancer.
Journal: Nucleic acids research
Published: August 06, 2018
The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 29, 2017
Last Updated: 09/26/2026